Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1475
-
Total 13F shares, excl. options
-
1.02B
-
Shares change
-
+1.47M
-
Total reported value, excl. options
-
$63.7B
-
Value change
-
+$28.3M
-
Put/Call ratio
-
1.41
-
Number of buys
-
486
-
Number of sells
-
-884
-
Price
-
$62.55
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2018
1,710 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2018.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,475 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.02B shares
of 1.24B outstanding shares and own 82.16% of the company stock.
Largest 10 shareholders include BlackRock Inc. (104M shares), Vanguard Group Inc (100M shares), Capital Research Global Investors (72.5M shares), STATE STREET CORP (56.1M shares), Bank of New York Mellon Corp (28.5M shares), Invesco Ltd. (19.7M shares), NORTHERN TRUST CORP (17M shares), GEODE CAPITAL MANAGEMENT, LLC (16.9M shares), DODGE & COX (16.5M shares), and Capital World Investors (15M shares).
This table shows the top 1475 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.